戻る Agenda
Strategic Directions from Global Medicines Regulators: The ICMRA Statement on Combatting Antimicrobial Resistance
Session Chair(s)
Agnès Saint-Raymond, DrMed
Head of Division International Affairs
European Medicines Agency, Netherlands
The ICMRA recognizes that antimicrobial resistance (AMR) is a complex, global and multi-faceted problem which poses unique challenges and is committing, in collaboration with WHO, to coordinate regulators efforts around the globe for the fight against AMR.
Learning Objective : Analyze the challenges faced by global regulators for development, commercialization and viability of products that tackle antimicrobial resistance (AMR) and formulate solutions; Recognize the role of the International Coalition of Medicines Regulatory Authorities (ICMRA) in providing strategic directions and coordination to global medicines regulators.
Speaker(s)
Health Canada Update
Pierre Sabourin, MBA
Health Canada, Canada
Assistant Deputy Minister, Health Products and Food Branch
Panelist
Guido Rasi, MD
Tor Vergata University of Rome, Italy
Chairman,Clinical Trial Center of Gemelli Polyclinic Inst; Prof of Microbiology
Panelist
John Farley, MD, MPH
FDA, United States
Director, Office of Infectious Diseases, OND, CDER
Panelist
Sini Eskola, MPHARM, MS, MSC
Takeda, Belgium
Head of International Regulatory Policy and Innovation